Evaluation of Parental Preference for the Treatment of Asthmatic Children Aged 6 to 11 Years with Oral Montelukast or Inhaled Cromolyn: A Randomized, Open-Label, Crossover Study
Don A. Bukstein(Institute for Asthma and Allergy), Jonathan M. Edelman(United States Military Academy), Donna L. Bratton(National Jewish Health), Carolyn M. Hustad(Merck & Co., Inc., Rahway, NJ, USA (United States)), Joanne Estojak(Merck & Co., Inc., Rahway, NJ, USA (United States)), Kelly M. Firriolo(Merck & Co., Inc., Rahway, NJ, USA (United States)), Steven Bird(Merck & Co., Inc., Rahway, NJ, USA (United States))
Cited by 39
Related Papers
Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
|The Lancet|2002|1.6k
Elastase-mediated phosphatidylserine receptor cleavage impairs apoptotic cell clearance in cystic fibrosis and bronchiectasis
|Journal of Clinical Investigation|2002|373
Elastase-mediated phosphatidylserine receptor cleavage impairs apoptotic cell clearance in cystic fibrosis and bronchiectasis
|Journal of Clinical Investigation|2002|324
The economic impact of allergic rhinitis and current guidelines for treatment
|Annals of Allergy Asthma & Immunology|2011|268
Shared decision making for the allergist
|Annals of Allergy Asthma & Immunology|2018|119